Slide 1 Humblet ASCO 2007 – Draft CONFIDENTIAL Association of skin toxicity (ST) severity with clinical outcomes and health-related quality of life (HRQoL) with panitumumab…

Slide 1 update in metastatic breast cancer Dr.Mina Tajvidi Radiation oncologist Slide 2 Fewer than 10 percent of women present with metastatic disease at the time of diagnosis…

IRESSA: A journey of experience from broad to biomarker populations Claire Watkins Global Product Statistician, AstraZeneca EFSPI meeting on Oncology Basel, 24th June 2010…

metastatic breast cancer update in metastatic breast cancer Dr.Mina Tajvidi Radiation oncologist 1 Fewer than 10 percent of women present with metastatic disease at the time…

Medtronic DBS Changing the course of Parkinsonâs Disease FOR PARKINSONâS DISEASE DBS Why Change The Course? Why Change The Course? TURN PAGE AND SEE OUR REASONS! Quality…